Theophylline
| Clinical data | |
|---|---|
| Trade names | Theolair, Slo-Bid |
| Other names | 1,3-dimethylxanthine |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a681006 |
| Pregnancy category |
|
| Routes of administration | By mouth, intravenous, rectal |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 100% (oral) |
| Protein binding | 40% (primarily to albumin) |
| Metabolism | Hepatic: CYP1A2, CYP2E1, CYP3A4 |
| Metabolites | • 1,3-Dimethyluric acid • 1-Methyixanthine • 3-Methylxanthine |
| Elimination half-life | 5–8 hours |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.350 |
| Chemical and physical data | |
| Formula | C7H8N4O2 |
| Molar mass | 180.167 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Theophylline, also known as 1,3-dimethylxanthine, is a drug that inhibits phosphodiesterase and blocks adenosine receptors. It is used to treat chronic obstructive pulmonary disease (COPD) and asthma. Its pharmacology is similar to other methylxanthine drugs (e.g., theobromine and caffeine). Trace amounts of theophylline are naturally present in tea, coffee, chocolate, yerba mate, guarana, and kola nut.